{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:10:29Z","timestamp":1787166629048,"version":"build-2736575974"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Department of Rheumatology"},{"name":"Tel-Aviv Sourasky Medical Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the impact of glucocorticoids (GCs) and anti-rheumatic drugs on lymphocyte activation gene-3 (LAG-3) and on programmed cell death-1 (PD-1) expression by synovial and peripheral cells ex vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Synovial fluid mononuclear cells (SFMCs) from psoriatic arthritis (PsA, n\u2009=\u200926) and rheumatoid arthritis (RA, n\u2009=\u200913) patients, synovial fluid cells (SFCs) from osteoarthritis (OA, n\u2009=\u20095) patients and peripheral blood mononuclear cells (PBMCs) of healthy donors (n\u2009=\u200914) were co-cultured with GCs, glucocorticoid receptor antagonist RU486, methotrexate (MTX) and biologics. LAG-3 and PD-1 expression on immune subsets were analysed by flow cytometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>GCs in PsA inhibited SFMC growth vs medium [2.3\u2009(0.4)\u2009\u00d7\u2009105vs 5.3\u2009(0.7)\u2009\u00d7\u2009105, respectively, P\u2009&amp;lt;\u20090.01] and markedly up-regulated CD14+LAG-3+ cells [11.7 (2.4)% vs 0.8 (0.3)%, P\u2009&amp;lt;\u20090.0001, respectively], but not CD3+LAG-3+ and CD14+PD-1+ cells. MTX had no effect on CD14+LAG-3+ cells [0.7\u2009(0.3)%]. The TNF inhibitors infliximab (IFX) and etanercept, but not IL-12\/23 inhibitor, up-regulated CD14+LAG-3+ cells vs medium [2.0\u2009(0.6)% and 1.6\u2009(0.4)% vs 0.5\u2009(0.1)%, P\u2009&amp;lt;\u20090.03, respectively]. SFMC growth inhibition by GC in both PsA and RA correlated with CD14+LAG-3+ cell up-regulation (r\u2009=\u20090.53, P\u2009=\u20090.03). RU486 inhibited GC-induced CD14+LAG-3+ cells up-regulation in a dose-dependent manner compared with GC alone [5\u2009\u00b5M 5.3\u2009(1.2)% and 50\u2009\u00b5M 1.3\u2009(0.5)% vs 7.0\u2009(1.4)%, P\u2009&amp;lt;\u20090.003], but had no significant effect on CD14+LAG-3+ cells co-cultured with IFX. GCs in healthy donors\u2019 PBMCs up-regulated the immune subsets CD3+LAG-3+, CD14+LAG-3+ and CD14+PD-1+ cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study proposes a novel regulatory mechanism of GCs and of TNF inhibitors mediated by LAG-3 up-regulation in synovial cells and PBMCs. LAG-3 modulation may be a promising target for development of novel therapies for inflammatory arthritis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae389","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T14:34:51Z","timestamp":1721918091000},"page":"1689-1697","source":"Crossref","is-referenced-by-count":4,"title":["A novel inhibitory pathway of synovial inflammation exerted by glucocorticoids and tumour necrosis factor inhibitors via lymphocyte activation gene-3 up-regulation: an\n                    <i>ex vivo<\/i>\n                    study"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7949-7184","authenticated-orcid":false,"given":"Smadar","family":"Gertel","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Tel-Aviv Sourasky Medical Center , Tel-Aviv,","place":["Israel"]},{"name":"Faculty of Medicine, Tel-Aviv University , Tel-Aviv,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2411-8084","authenticated-orcid":false,"given":"Ari","family":"Polachek","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tel-Aviv Sourasky Medical Center , Tel-Aviv,","place":["Israel"]},{"name":"Faculty of Medicine, Tel-Aviv University , Tel-Aviv,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2894-4033","authenticated-orcid":false,"given":"Tali","family":"Eviatar","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tel-Aviv Sourasky Medical Center , Tel-Aviv,","place":["Israel"]},{"name":"Faculty of Medicine, Tel-Aviv University , Tel-Aviv,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1873-8930","authenticated-orcid":false,"given":"Ori","family":"Elkayam","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tel-Aviv Sourasky Medical Center , Tel-Aviv,","place":["Israel"]},{"name":"Faculty of Medicine, Tel-Aviv University , Tel-Aviv,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5193-4207","authenticated-orcid":false,"given":"Victoria","family":"Furer","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tel-Aviv Sourasky Medical Center , Tel-Aviv,","place":["Israel"]},{"name":"Faculty of Medicine, Tel-Aviv University , Tel-Aviv,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"key":"2025040212115335400_keae389-B1","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0140-6736(18)30830-4","article-title":"The pathogenesis of psoriatic arthritis","volume":"391","author":"Veale","year":"2018","journal-title":"Lancet"},{"key":"2025040212115335400_keae389-B2","doi-asserted-by":"crossref","first-page":"e000656","DOI":"10.1136\/rmdopen-2018-000656","article-title":"Distinguishing rheumatoid arthritis from psoriatic arthritis","volume":"4","author":"Merola","year":"2018","journal-title":"RMD Open"},{"key":"2025040212115335400_keae389-B3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11926-011-0181-y","article-title":"Synovitis in psoriatic arthritis: immunohistochemistry, comparisons with rheumatoid arthritis, and effects of therapy","volume":"13","author":"van Kuijk","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"2025040212115335400_keae389-B4","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update","volume":"79","author":"Gossec","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2025040212115335400_keae389-B5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025040212115335400_keae389-B6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3899\/jrheum.170449","article-title":"Minimal disease activity as a treatment target in psoriatic arthritis: a review of the literature","volume":"45","author":"Gossec","year":"2018","journal-title":"J Rheumatol"},{"key":"2025040212115335400_keae389-B7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00063030-199809020-00002","article-title":"Intra-articular corticosteroids in arthritic disease: a guide to treatment","volume":"9","author":"Ostergaard","year":"1998","journal-title":"BioDrugs"},{"key":"2025040212115335400_keae389-B8","first-page":"694","article-title":"Corticosteroid injections for common musculoskeletal conditions","volume":"92","author":"Foster","year":"2015","journal-title":"Am Fam Physician"},{"key":"2025040212115335400_keae389-B9","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1148\/radiol.2019190341","article-title":"Intra-articular corticosteroid injections in the hip and knee: perhaps not as safe as we thought?","volume":"293","author":"Kompel","year":"2019","journal-title":"Radiology"},{"key":"2025040212115335400_keae389-B10","doi-asserted-by":"crossref","first-page":"17917","DOI":"10.1038\/s41598-018-36335-x","article-title":"Extracellular vesicles are associated with the systemic inflammation of patients with seropositive rheumatoid arthritis","volume":"8","author":"Burbano","year":"2018","journal-title":"Sci Rep"},{"key":"2025040212115335400_keae389-B11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13075-018-1798-2","article-title":"Synovial fluid monocyte\/macrophage subsets and their correlation to patient-reported outcomes in osteoarthritic patients: a cohort study","volume":"21","author":"Gomez-Aristizabal","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2025040212115335400_keae389-B12","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1136\/annrheumdis-2021-220280","article-title":"Ex vivo mass cytometry analysis reveals a profound myeloid proinflammatory signature in psoriatic arthritis synovial fluid","volume":"80","author":"Yager","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2025040212115335400_keae389-B13","doi-asserted-by":"crossref","first-page":"e109775","DOI":"10.1371\/journal.pone.0109775","article-title":"Functional phenotype of synovial monocytes modulating inflammatory T-cell responses in rheumatoid arthritis (RA)","volume":"9","author":"Yoon","year":"2014","journal-title":"PLoS One"},{"key":"2025040212115335400_keae389-B14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13075-020-02279-9","article-title":"Children with oligoarticular juvenile idiopathic arthritis have skewed synovial monocyte polarization pattern with functional impairment-a distinct inflammatory pattern for oligoarticular juvenile arthritis","volume":"22","author":"Schmidt","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2025040212115335400_keae389-B15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.intimp.2018.10.016","article-title":"Monocytes in rheumatoid arthritis: circulating precursors of macrophages and osteoclasts and, their heterogeneity and plasticity role in RA pathogenesis","volume":"65","author":"Rana","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"2025040212115335400_keae389-B16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/path.1891","article-title":"Synovial fluid macrophages are capable of osteoclast formation and resorption","volume":"208","author":"Adamopoulos","year":"2006","journal-title":"J Pathol"},{"key":"2025040212115335400_keae389-B17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fimmu.2015.00571","article-title":"The interplay between monocytes\/macrophages and CD4(+) T cell subsets in rheumatoid arthritis","volume":"6","author":"Roberts","year":"2015","journal-title":"Front Immunol"},{"key":"2025040212115335400_keae389-B18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/art.1780390116","article-title":"Synovial tissue macrophage populations and articular damage in rheumatoid arthritis","volume":"39","author":"Mulherin","year":"1996","journal-title":"Arthritis Rheum"},{"key":"2025040212115335400_keae389-B19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.2010.05919.x","article-title":"The role of the PD-1 pathway in autoimmunity and peripheral tolerance","volume":"1217","author":"Fife","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"2025040212115335400_keae389-B20","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.4049\/jimmunol.172.9.5450","article-title":"Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo","volume":"172","author":"Workman","year":"2004","journal-title":"J Immunol"},{"key":"2025040212115335400_keae389-B21","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41590-018-0217-9","article-title":"LAG-3 inhibits the activation of CD4(+) T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII","volume":"19","author":"Maruhashi","year":"2018","journal-title":"Nat Immunol"},{"key":"2025040212115335400_keae389-B22","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.4049\/jimmunol.2001188","article-title":"Lymphocyte activation gene-3 regulates dendritic cell metabolic programing and T cell priming function","volume":"207","author":"Garcia Cruz","year":"2021","journal-title":"J Immunol"},{"key":"2025040212115335400_keae389-B23","doi-asserted-by":"crossref","first-page":"2208373","DOI":"10.1080\/07853890.2023.2208373","article-title":"Diminished LAG3(+) B cells correlate with exacerbated rheumatoid arthritis","volume":"55","author":"Hu","year":"2023","journal-title":"Ann Med"},{"key":"2025040212115335400_keae389-B24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13075-017-1309-x","article-title":"Interleukin-10-producing LAG3(+) regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritis","volume":"19","author":"Nakachi","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2025040212115335400_keae389-B25","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.jid.2018.05.021","article-title":"Proportion of CD4(+)CD49b(+)LAG-3(+) type 1 regulatory T cells in the blood of psoriasis patients inversely correlates with psoriasis area and severity index","volume":"138","author":"Kim","year":"2018","journal-title":"J Invest Dermatol"},{"key":"2025040212115335400_keae389-B26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/cei.13646","article-title":"CD4(+) LAG-3(+) T cells are decreased in active psoriatic arthritis patients and their restoration in vitro is mediated by TNF inhibitors","volume":"206","author":"Gertel","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"2025040212115335400_keae389-B27","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2025040212115335400_keae389-B28","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2025040212115335400_keae389-B29","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheum"},{"key":"2025040212115335400_keae389-B30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/cei.12949","article-title":"Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1","volume":"188","author":"Bommarito","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"2025040212115335400_keae389-B31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1084\/jem.20100466","article-title":"PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice","volume":"208","author":"Okazaki","year":"2011","journal-title":"J Exp Med"},{"key":"2025040212115335400_keae389-B32","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/s42003-021-02931-3","article-title":"Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates","volume":"4","author":"Simone","year":"2021","journal-title":"Commun Biol"},{"key":"2025040212115335400_keae389-B33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13075-023-03073-z","article-title":"Lymphocyte activation gene 3 is increased and affects cytokine production in rheumatoid arthritis","volume":"25","author":"Pedersen","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"2025040212115335400_keae389-B34","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/ar2582","article-title":"Monocytes are essential for inhibition of synovial T-cell glucocorticoid-mediated apoptosis in rheumatoid arthritis","volume":"10","author":"Makrygiannakis","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"2025040212115335400_keae389-B35","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1111\/bph.15780","article-title":"Intra-articular injection of triamcinolone acetonide sustains macrophage levels and aggravates osteophytosis during degenerative joint disease in mice","volume":"179","author":"Ferrao Blanco","year":"2022","journal-title":"Br J Pharmacol"},{"key":"2025040212115335400_keae389-B36","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.4049\/jimmunol.1402409","article-title":"CD14++CD16+ monocytes are enriched by glucocorticoid treatment and are functionally attenuated in driving effector T cell responses","volume":"194","author":"Liu","year":"2015","journal-title":"J Immunol"},{"key":"2025040212115335400_keae389-B37","first-page":"1847","article-title":"Synovial monocytes from psoriatic and rheumatoid arthritis patients are modulated differently by TNF inhibitors and glucocorticoids: an ex-vivo study","volume":"41","author":"Gertel","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"2025040212115335400_keae389-B38","first-page":"29","article-title":"Overview of LAG-3-expressing, IL-10-producing regulatory T cells","volume":"410","author":"Fujio","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"2025040212115335400_keae389-B39","doi-asserted-by":"crossref","first-page":"19896","DOI":"10.1074\/jbc.RA119.010379","article-title":"Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cells","volume":"294","author":"Maeda","year":"2019","journal-title":"J Biol Chem"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae389\/58821237\/keae389.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/1689\/58821237\/keae389.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/1689\/58821237\/keae389.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T13:57:34Z","timestamp":1743602254000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/4\/1689\/7720987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,7,25]]},"published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae389","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,7,25]]}}}